United States: Supreme Court Weighs Major IP Pharma Issue - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Last month, the U.S. Supreme Court heard oral argument in the closely watched patent case, Amgen v. Sanofi. This long-running dispute involves the enablement requirement of 35 U.S.C. §112.